Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Org Biomol Chem ; 20(46): 9108-9111, 2022 11 30.
Artigo em Inglês | MEDLINE | ID: mdl-36350230

RESUMO

Among the valuable saturated bicyclic structures incorporated in newly developed bio-active compounds, bicyclo[2.1.1]hexanes are playing an increasingly important role, while being still underexplored from a synthetic accessibility point of view. Here, we disclose an efficient and modular approach toward new 1,2-disubstituted bicyclo[2.1.1]hexane modules. Our strategy is based on the use of photochemistry to access new building blocks via [2 + 2] cycloaddition. The system can readily be derivatized with numerous transformations, opening the gate to sp3-rich new chemical space.


Assuntos
Compostos Bicíclicos com Pontes , Hexanos , Hexanos/química , Compostos Bicíclicos com Pontes/química , Reação de Cicloadição
2.
Bioconjug Chem ; 33(10): 1860-1866, 2022 10 19.
Artigo em Inglês | MEDLINE | ID: mdl-36106863

RESUMO

Cleavable linkers have become the subject of intense study in the field of chemical biology, particularly because of their applications in the construction of antibody-drug conjugates (ADC), where they facilitate lysosomal cleavage and liberation of drugs from their carrier protein. Due to lysosomes' acidic nature, acid-labile motifs have attracted much attention, leading to the development of hydrazone and carbonate linkers among several other entities. Continuing our efforts in designing new moieties, we present here a family of cyclic acetals that exhibit excellent plasma stability and acid lability, notably in lysosomes. Incorporated in ADC, they led to potent constructs with picomolar potency in vitro and similar in vivo efficacy as the commercially available ADC Kadcyla in mouse xenograft models.


Assuntos
Antineoplásicos , Imunoconjugados , Camundongos , Animais , Humanos , Imunoconjugados/metabolismo , Acetais , Ado-Trastuzumab Emtansina , Linhagem Celular Tumoral , Antineoplásicos/metabolismo , Hidrazonas , Proteínas de Transporte
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...